"Eosinophilia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormal increase of EOSINOPHILS in the blood, tissues or organs.
Descriptor ID |
D004802
|
MeSH Number(s) |
C15.378.553.231
|
Concept/Terms |
Eosinophilia, Tropical- Eosinophilia, Tropical
- Eosinophilias, Tropical
- Tropical Eosinophilias
- Tropical Eosinophilia
|
Below are MeSH descriptors whose meaning is more general than "Eosinophilia".
Below are MeSH descriptors whose meaning is more specific than "Eosinophilia".
This graph shows the total number of publications written about "Eosinophilia" by people in this website by year, and whether "Eosinophilia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2004 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2016 | 3 | 1 | 4 |
2017 | 26 | 8 | 34 |
2018 | 13 | 12 | 25 |
2019 | 6 | 4 | 10 |
2020 | 6 | 0 | 6 |
2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Eosinophilia" by people in Profiles.
-
Eosinophilia and abdominal pain after severe pneumonia due to COVID 19. Enferm Infecc Microbiol Clin (Engl Ed). 2021 11; 39(9):478-480.
-
Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021 11; 9(11):1299-1312.
-
Protective effects of eosinophils against COVID-19: More than an ACE(2) in the hole? J Allergy Clin Immunol Pract. 2021 06; 9(6):2539-2540.
-
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19. Clin Microbiol Infect. 2021 08; 27(8):1190-1192.
-
Type 2 Immunity and Age Modify Gene Expression of Coronavirus-induced Disease 2019 Receptors in Eosinophilic Gastrointestinal Disorders. J Pediatr Gastroenterol Nutr. 2021 05 01; 72(5):718-722.
-
SARS-CoV-2 infection and COVID-19 in asthmatics: a complex relationship. Nat Rev Immunol. 2021 04; 21(4):202-203.
-
The relationship between asthma, eosinophilia, and outcomes in coronavirus disease 2019 infection. Ann Allergy Asthma Immunol. 2021 07; 127(1):42-48.
-
Eosinophilia in Asthma Patients Is Protective Against Severe COVID-19 Illness. J Allergy Clin Immunol Pract. 2021 03; 9(3):1152-1162.e3.
-
Type 2 Asthma Inflammation and COVID-19: A Double Edged Sword. J Allergy Clin Immunol Pract. 2021 03; 9(3):1163-1165.
-
Evaluation of eosinopenia as a diagnostic and prognostic indicator in COVID-19 infection. Int J Lab Hematol. 2021 Jul; 43 Suppl 1:137-141.